questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Troubles de la motricité
Syndromes parkinsoniens
Syndromes parkinsoniens : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Syndromes parkinsoniens
Diagnostic médical
Imagerie par résonance magnétique
Évaluation neuropsychologique
Bradykinésie
Tremblements
Maladie de Wilson
Syndromes atypiques
Historique médical
Facteurs de risque
Symptômes
5
Dépression
Troubles du sommeil
Évolution des symptômes
Syndromes parkinsoniens
Perte de l'odorat
Troubles du sommeil
Qualité de vie
Syndromes parkinsoniens
Prévention
5
Prévention
Mode de vie sain
Exercice physique
Santé neurologique
Alimentation
Antioxydants
Facteurs environnementaux
Pesticides
Stress
Progression de la maladie
Traitements
5
Lévodopa
Agonistes de la dopamine
Stimulation cérébrale profonde
Chirurgie
Effets secondaires
Médicaments
Physiothérapie
Ergothérapie
Traitements psychologiques
Symptômes non moteurs
Complications
5
Chutes
Troubles de la déglutition
Troubles cognitifs
Démence
Dépression
Isolement social
Approche multidisciplinaire
Gestion des complications
Facteurs de risque
5
Âge avancé
Antécédents familiaux
Sexe
Syndromes parkinsoniens
Traumatismes crâniens
Facteurs de risque
Exposition professionnelle
Produits chimiques
Maladies auto-immunes
Maladies métaboliques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndromes parkinsoniens : Questions médicales les plus fréquentes",
"headline": "Syndromes parkinsoniens : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndromes parkinsoniens : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles de la motricité",
"url": "https://questionsmedicales.fr/mesh/D009069",
"about": {
"@type": "MedicalCondition",
"name": "Troubles de la motricité",
"code": {
"@type": "MedicalCode",
"code": "D009069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndrome parkinsonien secondaire",
"alternateName": "Parkinson Disease, Secondary",
"url": "https://questionsmedicales.fr/mesh/D010302",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome parkinsonien secondaire",
"code": {
"@type": "MedicalCode",
"code": "D010302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie de Parkinson post-encéphalitique",
"alternateName": "Parkinson Disease, Postencephalitic",
"url": "https://questionsmedicales.fr/mesh/D010301",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Parkinson post-encéphalitique",
"code": {
"@type": "MedicalCode",
"code": "D010301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.662.600.700.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Syndromes parkinsoniens",
"alternateName": "Parkinsonian Disorders",
"code": {
"@type": "MedicalCode",
"code": "D020734",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sara Hall",
"url": "https://questionsmedicales.fr/author/Sara%20Hall",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Shorena Janelidze",
"url": "https://questionsmedicales.fr/author/Shorena%20Janelidze",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Oskar Hansson",
"url": "https://questionsmedicales.fr/author/Oskar%20Hansson",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden."
}
},
{
"@type": "Person",
"name": "Hash Brown Taha",
"url": "https://questionsmedicales.fr/author/Hash%20Brown%20Taha",
"affiliation": {
"@type": "Organization",
"name": "Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA."
}
},
{
"@type": "Person",
"name": "Carlo Colosimo",
"url": "https://questionsmedicales.fr/author/Carlo%20Colosimo",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Depression circuit adaptation in post-stroke depression.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37201899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.05.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissecting the depressed mood criterion in adult depression: The heterogeneity of mood disturbances in major depressive episodes.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36455714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2022.11.047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking treatment-resistant depression to quasi-tenacious depression.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36632817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2022.2353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37680180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2023.2448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Innate depression.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/scisignal.ade4885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles de la motricité",
"item": "https://questionsmedicales.fr/mesh/D009069"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndromes parkinsoniens",
"item": "https://questionsmedicales.fr/mesh/D020734"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndromes parkinsoniens - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndromes parkinsoniens",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndromes parkinsoniens",
"description": "Comment diagnostiquer un syndrome parkinsonien ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on confondre avec d'autres maladies ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndromes parkinsoniens",
"description": "Quels sont les symptômes moteurs principaux ?\nQuels symptômes non moteurs sont fréquents ?\nComment évoluent les symptômes ?\nY a-t-il des symptômes précoces ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndromes parkinsoniens",
"description": "Peut-on prévenir les syndromes parkinsoniens ?\nQuel rôle joue l'exercice physique ?\nL'alimentation influence-t-elle le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLe stress a-t-il un impact ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndromes parkinsoniens",
"description": "Quels sont les traitements médicamenteux ?\nLa chirurgie est-elle une option ?\nQuels sont les effets secondaires des médicaments ?\nY a-t-il des thérapies complémentaires ?\nComment gérer les symptômes non moteurs ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndromes parkinsoniens",
"description": "Quelles sont les complications courantes ?\nComment les chutes affectent-elles les patients ?\nLes troubles cognitifs sont-ils fréquents ?\nQuelles sont les complications psychologiques ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndromes parkinsoniens",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur ?\nL'exposition professionnelle joue-t-elle un rôle ?\nY a-t-il des liens avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D020734?mesh_terms=Depression#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un syndrome parkinsonien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes moteurs et non moteurs."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM et des évaluations neuropsychologiques peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la bradykinésie, la rigidité et les tremblements au repos."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Wilson ou des syndromes atypiques peuvent être confondues."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des facteurs de risque et des symptômes précurseurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes moteurs principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes moteurs incluent la bradykinésie, la rigidité, et les tremblements."
}
},
{
"@type": "Question",
"name": "Quels symptômes non moteurs sont fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes non moteurs incluent la dépression, l'anxiété et les troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes évoluent progressivement, souvent en s'aggravant avec le temps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes précoces ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la perte de l'odorat ou des troubles du sommeil peuvent apparaître tôt."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent considérablement réduire la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les syndromes parkinsoniens ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut améliorer la santé neurologique et retarder l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut réduire le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains pesticides et toxines peut augmenter le risque de Parkinson."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver les symptômes et influencer la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements médicamenteux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la lévodopa, les agonistes de la dopamine et les inhibiteurs de la COMT."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la stimulation cérébrale profonde peut être envisagée pour certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des mouvements involontaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies complémentaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie et l'ergothérapie peuvent aider à améliorer la fonction motrice."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes non moteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements psychologiques et des médicaments peuvent aider à gérer les symptômes non moteurs."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications courantes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les chutes, les troubles de la déglutition et les infections."
}
},
{
"@type": "Question",
"name": "Comment les chutes affectent-elles les patients ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chutes peuvent entraîner des blessures graves, comme des fractures, et réduire l'autonomie."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients développent des troubles cognitifs ou démence au cours de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients peuvent souffrir de dépression, d'anxiété et d'isolement social."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire est essentielle pour gérer les complications efficacement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les antécédents familiaux et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont généralement plus susceptibles de développer des syndromes parkinsoniens."
}
},
{
"@type": "Question",
"name": "Les traumatismes crâniens sont-ils un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traumatismes crâniens répétés peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle joue-t-elle un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposant à des produits chimiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des liens avec d'autres maladies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies auto-immunes et métaboliques peuvent être associées à un risque accru."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
3 publications dans cette catégorie
Affiliations :
Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, USA.
Department of Neurology, David Geffen School of Medicine at UCLA, University of California Los Angeles, 635 Charles E. Young Drive South/Gordon 451, Los Angeles, CA, 90095, USA.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Santa Maria University Hospital, Terni, Italy. Electronic address: carlo.colosimo@uniroma1.it.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Edmond J. Safra Parkinson Disease Program, Neurology Division, Toronto Western Hospital & Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Mölndal, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
UK Dementia Research Institute at UCL, London, United Kingdom.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Mölndal, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Multimodal Neuroimaging Group, Department of Nuclear Medicine, Faculty of Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Department of Neurology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Hosur Road, Bengaluru, 560029, Karnataka, India.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand. Electronic address: rbh@chulapd.org.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Advanced Brain Monitoring, Inc., Carlsbad, CA, USA. Electronic address: Dan@b-alert.com.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Memory and Aging Center, University of California, San Francisco, CA, USA.
Publications dans "Syndromes parkinsoniens" :
2 publications dans cette catégorie
Affiliations :
Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
Publications dans "Syndromes parkinsoniens" :
Lesion locations of post-stroke depression (PSD) mapped to a depression circuit which centered by the left dorsolateral prefrontal cortex (DLPFC). However, it remains unknown whether the compensatory ...
Rs-fMRI data were collected from 82 non-depressed stroke patients (Stroke), 39 PSD patients and 74 healthy controls (HC). We tested the existence of depression circuit, examined PSD-related alteration...
We found that: 1) the left DLPFC showed significantly stronger connectivity to lesions of PSD than Stroke group; 2) in comparison to both Stroke and HC groups, PSD exhibited increased connectivity wit...
Longitudinal studies are required to explore the alterations of depression circuit in PSD as the disease progress....
PSD underwent specific alterations in depression circuit, which may help to establish objective imaging markers for early diagnosis and interventions of the disease....
Mood disturbances have historically remained a core criterion in diagnosing major depressive episode. DSMs have illustrated this criterion with depressed, hopeless, discouraged, cheerless, and irritab...
The current study used a nationally representative sample of U.S. adults with unipolar major depressive disorder to study the association between specific forms of mood disturbances to depression seve...
Cheerless and hopeless mood were associated with depression severity. Hopeless and irritable mood were associated with depression chronicity. Different forms of mood disturbance showed differential re...
The relations between different forms of mood disturbances and various aspects of depression are nuanced. Theoretically, these relations highlight the potential utility in acknowledging the complexity...
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging. Recently, an es...
In the STAR*D study, the efficacy of treatments for major depression was examined. It was found that, while many responded to the initial antidepressant treatment, only 30% of participants achieved co...
Restoring AHI1 in macrophages may improve antiviral immunity in patients with depression....
Depressive disorders encompass a spectrum of diagnoses and are more common in women and transgender individuals. Diagnosis involves thorough history-taking and exclusion of underlying medical disorder...
To review and summarize the literature published between 1 January 2020 and 30 June 2022, on the prevalence, risk factors and impact of depression in transplant population....
Depression is common in transplantation candidates and recipients, with a prevalence up to 85.8% in kidney recipients. Multiple studies have indicated after transplantation depression correlates with ...
Depression is a common finding in transplant population. More research is needed to understand the biological substrate and risk factors and to develop effective treatment interventions....
The goal of this study was to explore the coping strategies of depression sufferers that have worked for them based on the study of an online depression community....
We conducted a thematic narrative analysis of 120 stories posted by the members in the largest online depression community in China. MaxQDA version 18 was used to code the data, and the analytic appro...
The study found that the coping strategies mainly include self-reconciliation (e.g., perceiving/accepting feelings, accepting the present self, and holding hope for the future), actions (recreational ...
The findings revealed the coping strategies that were helpful and examined how they functioned for the affected members, which make up for the lack of attention to the individual experiences of depres...
Evidence-based treatments for adult depression include psychotherapy and pharmacotherapy, yet little is known about how baseline depression severity moderates treatment outcome....
We aimed to compare the effects of psychotherapy and pharmacotherapy for adult depression and to examine the association between baseline depression severity and treatment outcome, converting multiple...
We conducted systematic searches in bibliographical databases up to September 2022 to identify randomized controlled trials (RCTs) in which psychotherapy was compared with pharmacotherapy in the treat...
We identified 65 RCTs including 7250 participants for the meta-analyses and 56 RCTs including 5548 participants for the meta-regression. We found no significant difference between psychotherapy and ph...
Limitations included the low quality of the included studies, and the omission of long-term effects and within-study variability....
We found no indication for a moderation effect of baseline depression severity on the relative effects of psychotherapy and pharmacotherapy. Thus, other factors such as availability and patients' pref...
Depression is a leading cause of disability, affecting approximately 300 million people globally [...]....